During the last session, Alzamend Neuro Inc (NASDAQ:ALZN)’s traded shares were 0.29 million, with the beta value of the company hitting -0.28. At the end of the trading day, the stock’s price was $3.02, reflecting an intraday gain of 1.68% or $0.05. The 52-week high for the ALZN share is $135.54, that puts it down -4388.08 from that peak though still a striking 3.97% gain since the share price plummeted to a 52-week low of $2.90. The company’s market capitalization is $2.42M, and the average trade volume was 1.53 million shares over the past three months.

Alzamend Neuro Inc (ALZN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. ALZN has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.

Alzamend Neuro Inc (NASDAQ:ALZN) trade information

Alzamend Neuro Inc (ALZN) registered a 1.68% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 1.68% in intraday trading to $3.02, hitting a weekly high. The stock’s 5-day price performance is -9.58%, and it has moved by -16.11% in 30 days. Based on these gigs, the overall price performance for the year is -92.62%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -11.45%. While earnings are projected to return 91.02% in 2025.

ALZN Dividends

Alzamend Neuro Inc is due to release its next quarterly earnings on 2025-Mar-10. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Alzamend Neuro Inc (NASDAQ:ALZN)’s Major holders

Alzamend Neuro Inc insiders own 3.22% of total outstanding shares while institutional holders control 0.88%, with the float percentage being 0.91%.